BARITHER

Medicine Information

Product information:

Barither Injection contains α-β Artemether 75 mg in an aqueous base of 2 ml. It is an antimalarial formulation used in the management of malaria as prescribed by a registered medical practitioner.

Artemether belongs to the artemisinin group of antimalarial medicines and acts against malaria-causing parasites.

Key Benefits:

Artemether acts quickly against blood‑stage Plasmodium falciparum, reducing parasite load.
Provides prompt relief from malarial fever and associated symptoms.
Injectable form ensures rapid action in complicated or resistant malaria cases.
Lowers risk of relapse compared to older antimalarials.
Generally safe with fewer gastrointestinal side effects than oral agents.
Suitable for patients unable to take oral medication due to vomiting or severe illness.

Directions for use:

Barither Injection should be administered only by a qualified healthcare professional and strictly according to the prescribed dosage and treatment regimen. The dose and duration of treatment should be determined based on the patient's age, body weight, clinical condition, and medical assessment. Do not self-administer.

Storage and Safety Information:

Store in a cool, dry place and protect from direct sunlight.
Keep out of reach of children.
For use under the supervision of a registered medical practitioner.
Do not self-administer.
Use only as prescribed and administered by a qualified healthcare professional.
Inform the doctor about any existing medical conditions or medicines being taken.
Use during pregnancy or breastfeeding only on the advice of a healthcare professional.
Do not use the product if the packaging is damaged or if the product shows any visible signs of deterioration.

Medicine Information

Product information:

Key Benefits:

Directions for use:

Storage and Safety Information:

Partner with us